Report If Experiencing Excessive Pain After Injecting The COVID-19 Vaccine
JAKARTA - Spokesman for the Task Force Handling COVID-19 Wiku Adisasmito reminded COVID-19 vaccine recipients who experience side effects or excess illness to immediately report to the nearest health facility.
"For any vaccine recipient who experiences unreasonable side effects or pain after vaccination, please report immediately to health facilities for the safety and health of each individual", Wiku said in a press conference which was broadcast online on the YouTube account of the Presidential Secretariat, Tuesday, March 23.
In addition to health, this reporting is a form of community participation in efforts to ensure the success of monitoring of post-immunization follow-up events (AEFI) carried out by the government.
Although this recommendation was conveyed, Wiku emphasized that the vaccines given by the community are safe, efficacious, halal, and have minimal side effects.
As for vaccine recipients until Saturday, March 20, there were 5 million people. "This is a positive achievement and must be improved so that more and more people can be protected from COVID-19", he said.
"Because I ask the public to be able to participate in this vaccination program, according to the predetermined schedule", added Wiku.
Previously reported, the national COVID-19 vaccination program is targeted to receive 181.5 million people. They are people aged 18 years and over. Vaccine recipients receive twice the injection dose.
In the first phase, the vaccine is intended for 1.5 million health workers. In the second stage, COVID-19 vaccination is for the elderly and public service workers.
The target is 21.5 million elderly and 16.9 million public workers. They are market traders, educators, religious leaders and counselors, representatives of the people, officials, government, civil servants, TNI-Police, tourism officers, public services, public transportation workers, athletes, and media workers. This program lasts until May.
Furthermore, vaccination will be carried out for 63.9 million vulnerable people or people living in areas with high risk of infection. Then, other communities as many as 77.7 million people.
This program will be carried out from April 2021 to March 2022.